Bottari S P, de Gasparo M, Steckelings U M, Levens N R
Cardiovascular Research Department, Ciba-Geigy Ltd., Basel, Switzerland.
Front Neuroendocrinol. 1993 Apr;14(2):123-71. doi: 10.1006/frne.1993.1005.
Thanks to the recent discovery of angiotensin II (ANG II) receptor subtypes linked to different signalling pathways, research in the different areas related to this peptide has regained a strong interest. In the following review, we first describe the biochemistry and actions of angiotensin peptides formed both in the circulation and locally at the tissue and organ level. Evidence for the existence and distribution of ANG II receptor subtypes in mammalian as well as in nonmammalian species and lower organisms is presented. The changes in receptor subtype expression during development and disease are described. The signal transduction mechanisms and biological actions of ANG II mediated by the recently cloned AT1 receptor are reviewed and the recent data concerning the signalling pathways linked to the AT2 receptor are discussed. Finally, based upon their molecular pharmacology, we present evidence and also speculate upon the physiological function of the ANG II receptor subtypes.
由于最近发现了与不同信号通路相关的血管紧张素 II(ANG II)受体亚型,与该肽相关的不同领域的研究重新引起了浓厚兴趣。在以下综述中,我们首先描述在循环系统以及组织和器官水平局部形成的血管紧张素肽的生物化学和作用。介绍了在哺乳动物、非哺乳动物物种以及低等生物中 ANG II 受体亚型的存在和分布证据。描述了发育和疾病过程中受体亚型表达的变化。综述了由最近克隆的 AT1 受体介导的 ANG II 的信号转导机制和生物学作用,并讨论了与 AT2 受体相关的信号通路的最新数据。最后,基于它们的分子药理学,我们提供证据并推测 ANG II 受体亚型的生理功能。